Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytek Biosciences, Inc. - Common Stock
(NQ:
CTKB
)
4.610
-0.080 (-1.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytek Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 03, 2023
Via
Benzinga
Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
February 28, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 14, 2023
Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
Via
Benzinga
Cytek Biosciences Acquires Flow Cytometry & Imaging Business From DiaSorin
↗
February 14, 2023
Via
Benzinga
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
February 13, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 07, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Earnings Perspective: Return On Capital Employed
↗
December 15, 2022
Via
Benzinga
Recap: Cytek Biosciences Q2 Earnings
↗
August 10, 2022
Cytek Biosciences (NASDAQ:CTKB) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:03 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Cytek Biosciences
↗
August 09, 2022
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Via
Benzinga
Where Cytek Biosciences Stands With Analysts
↗
July 14, 2022
Cytek Biosciences (NASDAQ:CTKB) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Participate in Upcoming Investor Conferences
February 06, 2023
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Oak Street Health, PriceSmart And Some Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
↗
January 10, 2023
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Earnings Scheduled For May 11, 2022
↗
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More
↗
December 15, 2022
The most oversold stocks in the healthcare sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
Cytek Biosciences to Participate in the Piper Sandler Healthcare Conference
November 21, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek® Biosciences Introduces Cytek Cloud
November 15, 2022
New Digital Ecosystem Supports Full Spectrum Flow Cytometry Research – from Panel Design to Data Acquisition
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences Reports Third Quarter 2022 Financial Results
November 09, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Earnings Outlook For Cytek Biosciences
↗
November 08, 2022
Cytek Biosciences (NASDAQ:CTKB) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Cytek...
Via
Benzinga
Cytek® Biosciences Names Chris Williams Chief Operating Officer
October 31, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
October 26, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Cytek to Participate in the 31st Annual Credit Suisse Healthcare Conference
October 26, 2022
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
↗
October 06, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Piper Sandler Maintains Overweight Rating for Cytek Biosciences: Here's What You Need To Know
↗
August 18, 2022
Piper Sandler has decided to maintain its Overweight rating of Cytek Biosciences (NASDAQ:CTKB) and raise its price target from $12.00 to $16.00. Shares of Cytek Biosciences are trading down 0.21%...
Via
Benzinga
Analyst Ratings for Cytek Biosciences
↗
August 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Analyst Ratings for Cytek Biosciences
↗
May 13, 2022
Over the past 3 months, 4 analysts have published their opinion on Cytek Biosciences (NASDAQ:CTKB) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding...
Via
Benzinga
74 Biggest Movers From Yesterday
↗
June 03, 2022
Gainers
Via
Benzinga
Goldman Sachs Maintains Buy Rating for Cytek Biosciences: Here's What You Need To Know
↗
May 12, 2022
Goldman Sachs has decided to maintain its Buy rating of Cytek Biosciences (NASDAQ:CTKB) and lower its price target from $14.00 to $12.00. Shares of Cytek Biosciences are trading up 10.93% over the last...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
April 21, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
